FIRST IN HUMAN TRIAL OF IMU-856, AN ORALLY AVAILABLE EPIGENETIC MODULATOR OF BARRIER REGENERATION FOR THE TREATMENT OF CELIAC DISEASE
A. James M. Daveson 1, 2
Franziska Burianek 3
Jelena Mihajlović 3
Evelyn Peelen 3
Juliano Fonseca 3
Amelie Schreieck 3
Martina Wirth 3
Inge Kehler 3
Daniel Vitt 3
Hella Kohlhof 3
Andreas Muehler 3
1 Wesley Medical Research, Auchenflower, Australia
2 Coral Sea Clinical Research Institute, North Mackay, Australia
3 Immunic AG, Gräfelfing, Germany
Topic
Small Intestine & Nutrition
Session
Coeliac disease (Posters)
Conference
UEG Week 2023
Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]